Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

JNJ

Johnson & Johnson

Feb 14 • 04:00PM ET

156.15

Dollar change -1.10
Percentage change -0.70	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: LLY PFE MRK AMGN BMY NVS ABBV GSK AZN MDT

| Held by: VTI VOO SPY IVV VTV XLV VIG VYM DGRO IWD

Scroll to Statements

Index	DJIA, S&P 500	P/E	26.93	EPS (ttm)	5.80	Insider Own	0.13%	Shs Outstand	2.41B	Perf Week	1.98%
Market Cap	375.95B	Forward P/E	14.13	EPS next Y	11.05	Insider Trans	-0.56%	Shs Float	2.40B	Perf Month	7.71%
Income	14.07B	PEG	5.46	EPS next Q	2.65	Inst Own	72.95%	Short Float	0.78%	Perf Quarter	2.30%
Sales	88.82B	P/S	4.23	EPS this Y	6.08%	Inst Trans	0.76%	Short Ratio	2.15	Perf Half Y	-1.47%
Book/sh	29.70	P/B	5.26	EPS next Y	4.37%	ROA	8.09%	Short Interest	18.76M	Perf Year	-0.20%
Cash/sh	10.19	P/C	15.33	EPS next 5Y	4.93%	ROE	20.06%	52W Range	140.68 - 168.85	Perf YTD	7.97%
Dividend Est.	5.10 (3.26%)	P/FCF	18.95	EPS past 5Y	0.55%	ROI	13.61%	52W High	-7.52%	Beta	0.48
Dividend TTM	4.91 (3.14%)	Quick Ratio	0.86	Sales past 5Y	2.03%	Gross Margin	68.71%	52W Low	11.00%	ATR (14)	2.36
Dividend Ex-Date	Feb 18, 2025	Current Ratio	1.11	EPS Y/Y TTM	3.69%	Oper. Margin	23.52%	RSI (14)	62.62	Volatility	1.38% 1.57%
Employees	138100	Debt/Eq	0.53	Sales Y/Y TTM	-4.51%	Profit Margin	15.84%	Recom	2.17	Target Price	168.94
Option/Short	Yes / Yes	LT Debt/Eq	0.45	EPS Q/Q	-15.14%	Payout	84.80%	Rel Volume	0.73	Prev Close	157.25
Sales Surprise	0.40%	EPS Surprise	2.43%	Sales Q/Q	5.27%	Earnings	Jan 22 BMO	Avg Volume	8.73M	Price	156.15
SMA20	2.76%	SMA50	5.28%	SMA200	1.31%	Trades		Volume	6,393,018	Change	-0.70%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-10-24	Resumed	BofA Securities	Neutral	$166
Nov-15-24	Initiated	Wolfe Research	Outperform	$190
Jul-23-24	Downgrade	Daiwa Securities	Outperform → Neutral	$160 → $150
May-30-24	Resumed	Goldman	Neutral	$160
Apr-18-24	Upgrade	HSBC Securities	Hold → Buy	$170
Dec-13-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$170 → $163
Dec-01-23	Upgrade	UBS	Neutral → Buy	$167 → $180
Oct-05-23	Initiated	RBC Capital Mkts	Outperform	$178
Sep-06-23	Initiated	HSBC Securities	Hold	$175
May-30-23	Resumed	Citigroup	Buy	$185
Mar-29-23	Initiated	UBS	Neutral	$164
Mar-01-23	Initiated	Guggenheim	Neutral	$161
Nov-18-22	Initiated	Credit Suisse	Neutral	$170
Oct-18-22	Initiated	Barclays	Equal Weight	$175
Oct-14-22	Reiterated	BofA Securities	Neutral	$185 → $178
Jun-22-22	Initiated	Daiwa Securities	Outperform
May-23-22	Resumed	SVB Leerink	Outperform	$200
Apr-06-22	Resumed	Morgan Stanley	Equal-Weight	$173
Mar-16-22	Downgrade	Bernstein	Outperform → Mkt Perform	$180 → $183
Mar-02-22	Resumed	BofA Securities	Neutral	$185

Show Previous Ratings

Today 06:37AM	Johnson & Johnson to resume market release of Varipulse catheter in US (Medical Device Network)
02:54AM	Why Johnson & Johnson (JNJ) Is One of the Best Drug Stocks to Buy Now (Insider Monkey)
Feb-15-25 01:00PM	Dividend Investor With $1.05 Million In Stocks And $36,600 Annual Payout Shares Portfolio 'Could These Picks Set You Up for Life?' (Benzinga)
12:28PM	Johnson & Johnson (JNJ): Among the Best Forever Stocks to Buy Right Now (Insider Monkey)
Feb-14-25 11:35AM	Jim Cramer on Johnson & Johnson (JNJ): Too Slow Growing (Insider Monkey)
08:00AM	Loading…
08:00AM	J&Js High Hopes for Heart-Rhythm Device Grounded by Safety Concerns (The Wall Street Journal)
Feb-13-25 12:31PM	J&J stops Phase III trial of Sanofis E. Coli vaccine citing disappointing results (Clinical Trials Arena)
08:30AM	Sanofi/Johnson & Johnson Partnered Vaccine Against Bacterial Sepsis Flunks Late-Stage Study (Benzinga)
08:05AM	New nipocalimab data published in mAbs journal details differentiated molecular design, clinical profile and potential of nipocalimab to treat IgG-driven alloantibody and autoantibody diseases (PR Newswire)
07:30AM	Congress Member Josh Gottheimer Dumps Nvidia, Microsoft, Loads Up On Tesla Stocks Instead (Benzinga)
06:31AM	Sanofi to take $250M charge on study failure for E. coli vaccine (BioPharma Dive)
Feb-12-25 10:37AM	Johnson & Johnson (JNJ): Jim Cramer on The Greatest Health Care Stock of All Time (Insider Monkey)
09:18AM	Why Johnson & Johnson (JNJ) is the Best Medical Device Stock to Buy (Insider Monkey)
07:11AM	Johnson & Johnson Explores Sale of Stroke Device Maker Cerenovus As MedTech Overhaul Accelerates (Benzinga)
Feb-11-25 02:27PM	Johnson & Johnson puts stroke care business up for sale (Financial Times)
06:02AM	Loading…
06:02AM	Invest with Confidence: Intrinsic Value Unveiled of Johnson & Johnson (GuruFocus.com)
Feb-09-25 05:30PM	Warren Buffett's Granddaughter Claimed He Cut Her Off And She Couldn't Afford Health Insurance: 'He Disowned My Twin Sister And Myself' (Benzinga)
12:30PM	Johnson & Johnson (JNJ) Among the Best Stocks to Buy for Financial Stability (Insider Monkey)
07:15AM	2 Stocks to Buy if There Is a Market Crash in 2025 (Motley Fool)
Feb-08-25 04:40AM	Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones? (Motley Fool)
Feb-07-25 09:00AM	Investors Heavily Search Johnson & Johnson (JNJ): Here is What You Need to Know (Zacks)
Feb-06-25 05:07AM	With uncertainty roiling Big Pharma, execs are placing lower-risk bets (Pharma Voice)
01:08AM	Surging dollar spurs jump in corporate FX hedging (Reuters)
Feb-05-25 09:59AM	Steady M&A Deals to Begin 2025, Disappointing IPOs So Far (GuruFocus.com)
09:06AM	Starboard Launches Proxy Fight at Kenvue (The Wall Street Journal)
Feb-04-25 06:01AM	Invest with Confidence: Intrinsic Value Unveiled of Johnson & Johnson (GuruFocus.com)
Feb-03-25 04:30PM	Johnson & Johnson to Participate in the 45th Annual TD Cowen Healthcare Conference (Business Wire)
08:02AM	Why Johnson & Johnson (JNJ) Is One of the Best Cancer Stock to Buy According to Hedge Funds (Insider Monkey)
04:30AM	ViiV Healthcare and J&Js adolescent HIV-1 combo gains EC authorisation (Pharmaceutical Technology)
03:50AM	Hospitals seek to intervene in J&J lawsuit against HHS to protect valuable drug discounts (Healthcare Dive)
02:23PM	Loading…
Feb-02-25 02:23PM	Is Johnson & Johnson (JNJ) the Most Promising Dividend Stock According to Hedge Funds? (Insider Monkey)
12:21PM	Is Johnson & Johnson Stock a Buy? (Motley Fool)
Feb-01-25 08:34AM	Is Johnson & Johnson (JNJ) the Best Defensive Stock to Buy Right Now? (Insider Monkey)
07:30AM	Johnson & Johnson Announces a Major Acquisition. Can It Turn the Stock's Fortunes Around? (Motley Fool)
06:14AM	Did Johnson & Johnson Just Give Investors 23 Billion Reasons to Buy Its Stock? (Motley Fool)
03:34AM	Why Johnson & Johnson (JNJ) Is Among the Best Long Term Low Risk Stocks to Buy Now (Insider Monkey)
Jan-31-25 05:12PM	US government could seek over $1 billion from J&J for cancer treatment costs (Reuters)
02:23PM	Johnson & Johnson (NYSE:JNJ) Posts Q4 Sales In Line With Estimates (StockStory)
Jan-30-25 12:18PM	Judge dismisses 2 counts in J&J pharmacy benefits lawsuit over upcharged drugs (HR Dive)
Jan-29-25 10:29PM	Is Johnson & Johnson (JNJ) the Safe Stock to Buy for the Long Term in 2025? (Insider Monkey)
02:04PM	Johnson & Johnson (JNJ): Is This Healthcare Stock A Good Buy? (Insider Monkey)
09:27AM	Is Johnson & Johnson (JNJ) Among Kevin OLearys Stock Picks for 2025? (Insider Monkey)
05:00AM	4 robotic surgery trends to watch in 2025 (MedTech Dive)
Jan-28-25 01:11PM	Jim Cramer Explains Why Johnson & Johnson (JNJ) Might Be Unfairly Judged by the Market Heres Why (Insider Monkey)
11:45AM	If You Invested $10,000 In Johnson & Johnson Stock 10 Years Ago, How Much Would You Have Now? (Benzinga)
09:40AM	Here's Why Johnson & Johnson (JNJ) is a Strong Value Stock (Zacks)
07:35AM	Why Johnson & Johnson (JNJ) Surged on Monday (Insider Monkey)
06:12AM	Jim Cramer Says You Should Buy Johnson & Johnson (JNJ) Dividend Stock With 3.3% Yield (Insider Monkey)
06:01AM	Navigating Market Uncertainty: Intrinsic Value of Johnson & Johnson (GuruFocus.com)
12:19AM	The Day DeepSeek Turned Tech and Wall Street Upside Down (The Wall Street Journal)
Jan-27-25 01:52PM	Jim Cramer Says Johnson & Johnson (JNJ) is Still Having A Problem With China (Insider Monkey)
09:00AM	Here is What to Know Beyond Why Johnson & Johnson (JNJ) is a Trending Stock (Zacks)
Jan-25-25 11:05AM	Is Johnson & Johnson (JNJ) The Best Bear Market Stock To Invest In Now? (Insider Monkey)
10:50AM	Is Johnson & Johnson (JNJ) Among The Stocks ChatGPT Predicts Could Make You Wealthy in 10 Years? (Insider Monkey)
06:17AM	These Were the 5 Worst-Performing Stocks in the Dow Jones Industrial Average in 2024 (Motley Fool)
Jan-24-25 07:14AM	Is Johnson & Johnson (JNJ) the Best Diversified Dividend Stock to Buy Now? (Insider Monkey)
04:51AM	5 of the Safest High-Yield Dividend Stocks You Can Confidently Buy for 2025 (Motley Fool)
02:01AM	Disasters Spawn New Businesses. The California Wildfires Will Do the Same. (Barrons.com)
Jan-23-25 04:57PM	Up About 62% in a Year, Can Intuitive Surgical Stock Keep Soaring? (Motley Fool)
03:40PM	Biotech Venture Investors Optimistic, But Uncertainties Persist (The Wall Street Journal)
02:01PM	Jim Cramer Likes Johnson & Johnson (JNJ) and the Kenvue Spin-Off Heres Why (Insider Monkey)
12:42PM	Is Johnson & Johnson (JNJ) the Best Halal Dividend Stock to Invest In Now? (Insider Monkey)
12:30PM	How HP, Johnson & Johnson And Rexford Industrial Realty Can Put Cash In Your Pocket (Benzinga)
11:45AM	Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now (Zacks)
08:08AM	Why Is Prem Watsa Bullish On Johnson & Johnson (JNJ) Now? (Insider Monkey)
08:00AM	Johnson & Johnson champions first-ever Canadian consensus paper identifying critical gaps in psoriasis care for patients with skin of colour (PR Newswire)
07:31AM	J&J Stock Dips 2% Despite Q4 Earnings Beat (GuruFocus.com)
05:35AM	Findings from pivotal nipocalimab Phase 3 study in a broad antibody positive population of people living with generalized myasthenia gravis (gMG) published in The Lancet Neurology (PR Newswire)
05:08AM	This Is 1 of the Healthiest High-Yielding Dividend Stocks You'll Find (Motley Fool)
02:02AM	Johnson & Johnson (JNJ) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amidst ... (GuruFocus.com)
01:01AM	Q4 2024 Johnson & Johnson Earnings Call (Thomson Reuters StreetEvents)
Jan-22-25 08:28PM	FDA approves Johnson & Johnsons ketamine-derived nasal spray for depression as standalone treatment (Fortune)
04:41PM	J&J posts a Q4 earnings beat, but headwinds remain (Yahoo Finance Video)
04:33PM	J&J Skids After Dow Giant Beat Earnings Views, But 'Prudent' Guidance Disappoints (Investor's Business Daily)
04:32PM	3-Stock Lunch: Netflix, Johnson & Johnson, Travelers (CNBC TV)
03:52PM	Heres Why Johnson & Johnson (JNJ) Is Among the Highest Yielding Dividend Stocks In the Dow (Insider Monkey)
02:16PM	Analyst Report: Johnson & Johnson (Morningstar Research)
02:00PM	Johnson & Johnson (JNJ) Q4 2024 Earnings Call Transcript (Motley Fool)
01:44PM	Is Johnson & Johnson (JNJ) the Best Stock to Invest In For Steady Dividends? (Insider Monkey)
12:54PM	China to remain a headwind in 2025 for J&J MedTech, CFO says (Medical Device Network)
12:48PM	AstraZeneca gains NICE nod for lung cancer drugs Tagrisso and Imfinzi (Pharmaceutical Technology)
12:03PM	Downside risk from talc lawsuit, Stelara generic competition is 'manageable': JNJ CFO Joe Wolk (Yahoo Finance)
11:32AM	Johnson & Johnson Reports Q4, Full-Year 2024 Results with Revenue Growth (GuruFocus.com)
11:15AM	Is Johnson & Johnson (JNJ) Expected to Post Impressive Earnings This Week? (Insider Monkey)
10:22AM	Johnson & Johnson stock down despite beat on full-year, Q4 2024 earnings (Yahoo Finance)
09:36AM	J&J, Procter & Gamble, United Airlines: Earnings movers (Yahoo Finance Video)
09:30AM	Compared to Estimates, Johnson & Johnson (JNJ) Q4 Earnings: A Look at Key Metrics (Zacks)
09:09AM	Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth (Barrons.com)
08:25AM	J&J Tops Q4 Adjusted Earnings Estimates, But 2025 Sales Outlook Falls Short (Investopedia)
08:21AM	Johnson & Johnson Q4 Earnings: Cancer Drugs Performance Drives Revenue Beat, Issues Strong FY25 Outlook (Benzinga)
07:34AM	Johnson & Johnson Earnings Narrowly Top But Dow Giant's Sales Guidance Light (Investor's Business Daily)
07:30AM	Johnson & Johnson (JNJ) Q4 Earnings and Revenues Top Estimates (Zacks)
06:29AM	Johnson & Johnson: Q4 Earnings Snapshot (Associated Press Finance)
06:23AM	J&J beats quarterly sales and profit estimates on cancer drug sales (Reuters)
06:20AM	Johnson & Johnson Reports Q4 and Full-Year 2024 Results (Business Wire)
Jan-21-25 09:46PM	Jim Cramer on Johnson & Johnson (JNJ): 'Make Good Money Just By Reinvesting Their Juicy Dividends' (Insider Monkey)
07:00PM	P&G earnings, mortgage applications: What to Watch (Yahoo Finance Video)
11:57AM	FDA Approves Johnson & Johnson's Treatment As First Monotherapy For Treatment-Resistant Depression (Benzinga)
11:42AM	J&J's Spravato Wins FDA Approval, Stands as a Game-Changer for Mental Health Care (GuruFocus.com)
08:00AM	SPRAVATO (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression (PR Newswire)

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Duato Joaquin	CEO and Chairman of the Board	Feb 07 '25	Option Exercise	100.06	126,369	12,644,482	489,671	Feb 11 07:43 PM
Wengel Kathryn E	EVP, Chief TO and Risk Officer	Feb 07 '25	Option Exercise	100.06	32,762	3,278,166	115,028	Feb 11 07:42 PM
Taubert Jennifer L	EVP, WWC. Innovative Medicine	Feb 07 '25	Option Exercise	100.06	58,504	5,853,910	213,355	Feb 11 07:41 PM
Wolk Joseph J	Exec VP, CFO	Feb 07 '25	Option Exercise	100.06	13,015	1,302,281	13,015	Feb 11 07:40 PM
Wolk Joseph J	Exec VP, CFO	Feb 07 '25	Sale	153.89	13,015	2,002,878	0	Feb 11 07:40 PM
Wolk Joseph J	Officer	Feb 07 '25	Proposed Sale	153.89	13,015	2,002,924		Feb 07 01:27 PM
WEINBERGER MARK A	Director	Dec 12 '24	Buy	147.22	1,000	147,220	1,000	Dec 12 05:27 PM
Hait William	Former Officer	Dec 04 '24	Proposed Sale	149.90	25,742	3,858,598		Dec 04 01:25 PM
Decker Robert J	VP Corporate Controller	Aug 30 '24	Option Exercise	100.06	5,635	563,838	24,608	Sep 03 04:48 PM
Decker Robert J	VP Corporate Controller	Aug 30 '24	Sale	165.06	5,635	930,113	18,973	Sep 03 04:48 PM
Decker Robert J	Officer	Aug 30 '24	Proposed Sale	165.06	5,635	930,113		Aug 30 03:51 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Jul 08 '24	Option Exercise	0.00	9,809	0	24,852	Jul 09 05:48 PM
REED JOHN C	EVP, Innovative Medicine, R&D	May 01 '24	Option Exercise	0.00	22,255	0	22,561	May 03 04:31 PM
Broadhurst Vanessa	EVP, Global Corp Affairs	Mar 13 '24	Sale	162.16	8,891	1,441,765	15,043	Mar 13 04:36 PM
JOHNSON & JOHNSON	10% Owner	Feb 29 '24	Option Exercise	0.72	3,855	2,792	4,103,430	Mar 06 03:42 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

JNJ

Johnson & Johnson

Upgrade your FINVIZ experience